Departamento de Ciencias Médicas y Quirúrgicas

 

En esta Comunidad se recogen los documentos generados por el Departamento de Ciencias Médicas y Quirúrgicas y que cumplen los requisitos de Copyright para su difusión en acceso abierto.

Este departamento cambia su denominación en 2020, anteriormente: Medicina (Medicina, Dermatología y Otorrinolaringología)

Si usted es miembro del Departamento y desea depositar un documento puede enviarnos un mensaje.

Creative Commons License
Los contenidos se encuentran sujetos bajo una Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International License.

Collections in this community

Recent Submissions

  • Valoración de la hiperreactividad bronquial alergenoespecífica en pacientes asmáticos sometidos a tratamiento inmunoterápico 

    Arenas Vacas, Antonio Pablo (Universidad de Córdoba, UCOPress, 1991)

  • Residual cardiovascular risk: When should we treat it? 

    Gómez Delgado, Francisco; Raya-Cruz, Manuel; Katsiki, Niki; Delgado-Lista, Javier; Pérez Martínez, Pablo (Elsevier, 2023)
    Cardiovascular disease (CVD) still being the most common cause of death in worldwide. In spite of development of new lipid-lowering therapies which optimize low-density lipoprotein cholesterol (LDL-c) levels, recurrence ...

  • Alirocumab and Coronary Atherosclerosis in Asymptomatic Patients with Familial Hypercholesterolemia: The ARCHITECT Study 

    Pérez de Isla, Leopoldo; Díaz-Díaz, José Luis; Romero, Manuel J.; Muñiz-Grijalvo, Ovidio; Mediavilla, Juan D.; Argüeso, Rosa; Sánchez Muñoz-Torrero, Juan; Rubio, Patricia; Álvarez-Baños, Pilar; Ponte, Paola; Mañas, María Dolores; Suárez Gutierrez, Lorena; Cepeda, José María; Casañas, Marta; Fuentes, Francisco; Guijarro, Carlos; Barba, Miguel A.; Saltijeral Cerezo, Adriana; Padró, Teresa; Mata, Pedro (American Heart Association, 2023)
    Background:The effect of alirocumab, a PCSK9 (proprotein convertase subtilisin/kexin type 9) inhibitor, on coronary plaque burden in patients with familial hypercholesterolemia has not been addressed. Our aim was to assess ...

  • Prior Treatment with Statins is Associated with Improved Outcomes of Patients with COVID-19: Data from the SEMI-COVID-19 Registry 

    Torres‑Peña, J.D.; Pérez-Belmonte, Luis M.; Fuentes-Jiménez, Francisco J.; López-Carmona, María D.; Pérez-Martinez, Pablo; López-Miranda, José; Carrasco Sánchez, Francisco Javier; Vargas-Núñez, Juan-Antonio; Del Corral Beamonte, Esther; Magallanes Gamboa, Jeffrey Oskar; González García, Andrés; González Moraleja, Julio; Cortés Troncoso, Andrés; Taboada Martínez, María Luisa; Del Fidalgo Montero, María del Pilar; Seguí Ripol, José Miguel; Gil Sánchez, Ricardo; Alegre González, Diana; Boixeda, Ramón; Cortés Rodríguez, Begoña; Ena, Javier; García-García, Gema-María; Ventura Esteve, Ana; Ramos-Rincón, José Manuel; Gómez-Huelgas, Ricardo (Springer Nature, 2021)
    Background The impact of statins on COVID-19 outcomes is important given the high prevalence of their use among individuals at risk for severe COVID-19. Our aim is to assess whether patients receiving chronic statin treatment ...

  • Higher education students' perceptions of ChatGPT: A global study of early reactions 

    Ravšelj, Dejan; Keržič, Damijana; Tomaževič, Nina; Umek, Lan; Brezovar, Nejc; A Iahad, Noorminshah; Abdulla, Ali Abdulla; Akopyan, Anait; Segura, Magdalena Waleska Aldana; AlHumaid, Jehan; Farouk Allam, Mohamed (PLoS, 2025)
    The paper presents the most comprehensive and large-scale global study to date on how higher education students perceived the use of ChatGPT in early 2024. With a sample of 23,218 students from 109 countries and territories, ...

View more